Elske Sieswerda

1.8k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Elske Sieswerda is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Elske Sieswerda has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pediatrics, Perinatology and Child Health, 12 papers in Public Health, Environmental and Occupational Health and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Elske Sieswerda's work include Childhood Cancer Survivors' Quality of Life (16 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Palliative Care and End-of-Life Issues (6 papers). Elske Sieswerda is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (16 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Palliative Care and End-of-Life Issues (6 papers). Elske Sieswerda collaborates with scholars based in Netherlands, United States and United Kingdom. Elske Sieswerda's co-authors include Leontien C.M. Kremer, Elvira C van Dalen, Helena J. H. van der Pal, Flora E. van Leeuwen, Huib N. Caron, Ronald B. Geskus, Wim J. E. Tissing, Wouter E.M. Kok, Helena van der Pal and Caro C.E. Koning and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Elske Sieswerda

31 papers receiving 1.0k citations

Hit Papers

Recommendations for cardiomyopathy surveillance for survi... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
    2015 341 citations Renée L. Mulder, Wim J. E. Tissing et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elske Sieswerda Netherlands 15 510 467 238 164 162 35 1.1k
Lyen C. Huang United States 20 172 0.3× 54 0.1× 153 0.6× 359 2.2× 163 1.0× 53 1.1k
Wolfgang Stöhr United Kingdom 22 78 0.2× 233 0.5× 121 0.5× 103 0.6× 165 1.0× 65 1.6k
Gerard J. Boyle United States 16 301 0.6× 85 0.2× 69 0.3× 92 0.6× 130 0.8× 31 951
Cosmin Cîtu Romania 16 46 0.1× 62 0.1× 142 0.6× 153 0.9× 63 0.4× 70 849
Jürgen Dinger Germany 23 166 0.3× 495 1.1× 912 3.8× 50 0.3× 293 1.8× 67 1.8k
Sohail R. Shah United States 22 143 0.3× 103 0.2× 150 0.6× 106 0.6× 326 2.0× 81 1.5k
Valerio Cecinati Italy 16 66 0.1× 79 0.2× 72 0.3× 93 0.6× 87 0.5× 61 735
Flavia Ventriglia Italy 15 194 0.4× 157 0.3× 18 0.1× 64 0.4× 128 0.8× 67 696
Katelin B. Nickel United States 17 61 0.1× 37 0.1× 67 0.3× 201 1.2× 118 0.7× 77 960
Atakan Tanaçan Türkiye 20 56 0.1× 504 1.1× 433 1.8× 185 1.1× 92 0.6× 192 1.5k

Countries citing papers authored by Elske Sieswerda

Since Specialization
Citations

This map shows the geographic impact of Elske Sieswerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elske Sieswerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elske Sieswerda more than expected).

Fields of papers citing papers by Elske Sieswerda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elske Sieswerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elske Sieswerda. The network helps show where Elske Sieswerda may publish in the future.

Co-authorship network of co-authors of Elske Sieswerda

This figure shows the co-authorship network connecting the top 25 collaborators of Elske Sieswerda. A scholar is included among the top collaborators of Elske Sieswerda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elske Sieswerda. Elske Sieswerda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Linden, Paul D. van der, Jan Jelrik Oosterheert, Elske Sieswerda, et al.. (2025). Short-course aminoglycosides as adjunctive treatment in adults with sepsis: A post-hoc analysis of a prematurely terminated cluster randomized trial. University of Groningen research database (University of Groningen / Centre for Information Technology). 2(2). 105075–105075.
3.
Minotti, Chiara, Kerstin Jost, Soheila Aghlmandi, et al.. (2025). All-cause mortality and infection-related outcomes of hospital-initiated kangaroo care versus conventional neonatal care for low-birthweight infants: a systematic review and meta-analysis. The Lancet Child & Adolescent Health. 9(7). 470–483. 2 indexed citations
4.
Timmerhuis, Hester C., Lotte Boxhoorn, Rogier P. Voermans, et al.. (2025). Predictors for Successful Treatment of Infected Necrotizing Pancreatitis With Antibiotics Alone. Annals of Surgery. 282(5). 860–867.
5.
Torensma, Bart, Suzanne Van Asten, Elske Sieswerda, et al.. (2024). Duration of Antibiotic Treatment for Foot Osteomyelitis in People with Diabetes. Antibiotics. 13(12). 1173–1173. 1 indexed citations
6.
Buis, David T.P., Thomas W. van der Vaart, Jan M. Prins, et al.. (2023). Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study. Journal of Antimicrobial Chemotherapy. 78(5). 1175–1181. 3 indexed citations
7.
Huynh, Jennifer, Elske Sieswerda, Nick de Jonge, et al.. (2022). Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study. Antimicrobial Resistance and Infection Control. 11(1). 160–160. 8 indexed citations
8.
Sieswerda, Elske, Hannelore I. Bax, Jacobien J. Hoogerwerf, et al.. (2022). The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults. BMC Infectious Diseases. 22(1). 687–687. 9 indexed citations
9.
Buis, David T.P., Elske Sieswerda, Ilse J.E. Kouijzer, et al.. (2022). [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review. BMC Infectious Diseases. 22(1). 282–282. 11 indexed citations
10.
Buis, David T. P., Lilian J. Meijboom, Rogier P. Schade, et al.. (2021). Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study. Antimicrobial Resistance and Infection Control. 10(1). 155–155. 17 indexed citations
11.
Wielenga, Mattheus C.B., Paul Fockens, Cyriel Y. Ponsioen, et al.. (2021). Antibiotic Therapy of 3 Days May Be Sufficient After Biliary Drainage for Acute Cholangitis: A Systematic Review. Digestive Diseases and Sciences. 66(12). 4128–4139. 12 indexed citations
12.
Heijer, Martin den, Vincent de Groot, Max Nieuwdorp, et al.. (2021). Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial. Trials. 22(1). 517–517. 10 indexed citations
13.
Sieswerda, Elske, Mark de Boer, Marc J. M. Bonten, et al.. (2020). Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline. Clinical Microbiology and Infection. 27(1). 61–66. 125 indexed citations
14.
Sieswerda, Elske, Anna Font‐Gonzalez, Johannes B. Reitsma, et al.. (2016). High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage. PLoS ONE. 11(7). e0159518–e0159518. 21 indexed citations
15.
Dijk, Irma W.E.M. van, Helena J. H. van der Pal, Rob M. van Os, et al.. (2016). Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis. International Journal of Radiation Oncology*Biology*Physics. 96(3). 597–605. 27 indexed citations
16.
Pal, Helena J. H. van der, Ronald B. Geskus, Wouter E.M. Kok, et al.. (2014). Valvular Abnormalities Detected by Echocardiography in 5-Year Survivors of Childhood Cancer: A Long-Term Follow-Up Study. International Journal of Radiation Oncology*Biology*Physics. 91(1). 213–222. 11 indexed citations
17.
Sieswerda, Elske, Renée L. Mulder, Irma W.E.M. van Dijk, et al.. (2013). The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability. Journal of Cancer Survivorship. 7(3). 439–454. 17 indexed citations
18.
Sieswerda, Elske, A. Postma, Elvira C van Dalen, et al.. (2012). The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Annals of Oncology. 23(8). 2191–2198. 37 indexed citations
19.
Sieswerda, Elske, Leontien C.M. Kremer, H.N. Caron, & Elvira C van Dalen. (2011). The use of liposomal anthracycline analogues for childhood malignancies: A systematic review. European Journal of Cancer. 47(13). 2000–2008. 22 indexed citations
20.
Sieswerda, Elske, Leontien C.M. Kremer, Suzanna Vidmar, et al.. (2009). Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: A prospective follow‐up study. Pediatric Blood & Cancer. 54(4). 579–584. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lyen C. Huang Breakdown of academic impact, for papers by Wolfgang Stöhr Breakdown of academic impact, for papers by Gerard J. Boyle Breakdown of academic impact, for papers by Cosmin Cîtu Breakdown of academic impact, for papers by Jürgen Dinger Breakdown of academic impact, for papers by Sohail R. Shah Breakdown of academic impact, for papers by Valerio Cecinati Breakdown of academic impact, for papers by Flavia Ventriglia Breakdown of academic impact, for papers by Katelin B. Nickel Breakdown of academic impact, for papers by Atakan Tanaçan
Rankless by CCL
2026